Table 2.
Association between DCBLD2 expression and clinicopathological features of patients with LUAD from Tianjin Medical University Cancer Institute and Hospital. Cut off: H score = 5, * p < 0.05, ** p < 0.01, Chi-square test, except for #: Fisher test.
Characteristics | Total (n = 125) |
DCBLD2 Expression | χ2 | p Value | |
---|---|---|---|---|---|
Low (n = 37) | High (n = 88) | ||||
Gender | 1.926 | 0.165 | |||
Male | 59 | 21 | 38 | ||
Female | 66 | 16 | 50 | ||
Age (year) | 0.826 | 0.363 | |||
<65 | 91 | 29 | 62 | ||
≥65 | 34 | 8 | 26 | ||
T staging | 0.409 | 0.523 | |||
T1 | 52 | 17 | 35 | ||
T2–T4 | 73 | 20 | 53 | ||
Nodal staging | 7.119 | 0.008 ** | |||
N0–N1 | 83 | 31 | 52 | ||
N2–N3 | 42 | 6 | 36 | ||
M staging | 1.000 # | ||||
M0 | 124 | 37 | 87 | ||
M1 | 1 | 0 | 1 | ||
TNM | 6.406 | 0.011 * | |||
I | 56 | 23 | 33 | ||
II,III,IV | 69 | 14 | 55 |